NeuroGyn is not a device company.

NeuroGyn is the owner of a fully patented neuromodulation ecosystem.

NeuroGyn has created and owns a vertically integrated, globally protected therapeutic platform that covers, in a unified intellectual property architecture:

• neuromodulation procedures (Laparoscopic Implantation Of Neuroprostehsis – LION®, Genital Nerves Stimulation – GNS®)
• proprietary nerve targets and therapeutic algorithms
• novel disease indications including chronic pelvic neuropathic pain, pelvic organ dysfunction, erectile dysfunction, osteoporosis, depression, arterial hypertonia and other systemic autonomic disorders
• diagnostic and clinical workflow pathways
• and proprietary implantable neuromodulation hardware

Together, these components form a fully patented therapeutic operating system, not a product.

A PROTECTED MEDICAL PLATFORM – NOT A PRODUCT

Unlike conventional neuromodulation companies that market standalone devices, NeuroGyn Ecosystem controls the entire therapeutic chain:

• patented procedures
• patented indications
• patented nerve targets
• standardized clinical workflows
• integrated training & certification of surgeons in LION&GNS procedures 
• and proprietary implantable device hardware (PosStim®)

This creates an unprecedented level of clinical reproducibility, safety, and global IP protection.

THE INTERNATIONAL SCHOOL FOR NEUROPELVEOLOGY (ISNP – www.possover-neuropelveology.com)

NeuroGyn is supported by its official academic pillar, the International School for Neuropelveology (ISNP), which represents the educational engine of the NeuroGyn ecosystem.

ISNP has already trained and certified more than 200 international key surgeons (mainly gynecolgists) in neuropelveology and pelvic neuromodulation, creating the world’s first generation of clinicians formally educated in:

• neuropelveology (www.theison.org) 
• LION® and GNS® procedures
• pelvic nerve diagnostics
• nerve-centric endometriosis surgery

• laparoscopic pelvic neurosurgery
• neuromodulation-based organ dysfunction management

This global physician network forms the clinical deployment backbone of NeuroGyn’s therapeutic platform.

SCIENTIFIC LEADERSHIP

The NeuroGyn ecosystem is founded and scientifically led by
Prof. Prof. DO Prof. h.c. (China) Dr. med. Marc Possover, founder of Neuropelveology, pioneer of pelvic neuromodulation, and author of more than three decades of peer-reviewed scientific publications defining pelvic nerve surgery and neuromodulation worldwide.

He is the first to introduce and establish neuromodulation as a therapeutic discipline in gynecology, thereby opening the door to bioelectronic medicine in women’s health and pelvic organ dysfunction.

For his groundbreaking contributions to medicine, Prof. Possover is member of the French National Academy of Surgery and has been awarded the French National Order of the Légion d’Honneur, one of Europe’s highest distinctions for scientific and medical excellence.

NeuroGyn’s scientific architecture is continuously expanded through international research collaborations, clinical trials, and next-generation digital neuromodulation initiatives.

WHY THIS MATTERS

NeuroGyn is building the first neuromodulation platform capable of treating pelvic and systemic nerve disorders as programmable biological circuits, creating a protected medical operating system for the next era of bioelectronic medicine.

This is not just a product.
This is the future therapeutic infrastructure.